Cancer Singapore | National University Cancer Institute, Singapore (NCIS) > Patient and Visitors > Join a Research Study

Join a Research Study

CHEMOTHERAPY TOXICITY SCORE PREDICTION STUDY IN ASIAN PATIENTS


Join our study in validating the Cancer and Ageing Research Group (CARG) chemotherapy toxicity prediction score in Asian patients. The guided questionnaire will take about 30-45 minutes to complete. Participants will be reimbursed.

 

Eligibility:


  • Cancer patient aged 70 and above
  • Planning to go for chemotherapy

 

Click here for more information.

 

STUDY ON IMPACT OF A GERIATRIC ONCOLOGY SERVICE ON THE QUALITY OF LIFE IN PATIENTS


Help us to provide better care for elderly cancer patients aged 70 and above. Be part of our study to find out the impact of a Geriatric Oncology service on the Quality of Life of patients and if it can help reduce caregiver distress. Participants will be reimbursed.


Eligibility:


  • Cancer patient aged 70 and above
  • Seen as an Outpatient at the National University Cancer Institute, Singapore (NCIS)
  • Caregiver of a patient who fulfills the above criteria

Click here for more information.

 

"BE IN THE PINK" STUDY ON HOW REHABILITATION CAN PLAY A PART IN IMPROVING YOUR WELL-BEING

 

If you are a breast cancer patient who will be going for chemotherapy and / or targeted therapy, we need you. Help us in our study "The Feasibility and Efficacy of Multi-disciplinary Team-based Rehabilitation". This programme "Be in the PINK" aims to reduce symptoms and improve well-being through a series of exercise classes and educational talks. 

 

Eligiblity:


  • Breast cancer patient from 20 - 80 years old
  • Going for chemotherapy and / or on targeted therapy
  • Able to walk independently without use of aids
  • Able to read and understand English

Click here for more information.

 

 

 

STUDY ON THE IMPACT OF EXERCISE IN PATIENTS WITH EARLY BREAST CANCER 

 

Patients who are completing their cancer treatment are invited to participate in this study that compares an exercise programme versus observation on the impact of mental health, quality of life and immune markers. Allocation to either group is based on controlled randomisation. 

 

Eligiblity: 


  • Females between 21 - 70 years old who are undergoing / have undergone curative treatment
  • Stage 1 - 3 Breast Cancer
  • Between 4 to 12 weeks from last chemotherapy / radiation therapy / breast cancer surgery treatment
  • Able to adhere to study procedures
  • No medical issues deemed by investigator to be unsuitable for study 

Click here for more information.